Aerie Pharmaceuticals
AERI
#6003
Rank
HK$5.86 B
Marketcap
HK$118.69
Share price
0.00%
Change (1 day)
83.52%
Change (1 year)

Earnings for Aerie Pharmaceuticals (AERI)

Earnings in 2022 (TTM): -HK$0.19 Billion

According to Aerie Pharmaceuticals's latest financial reports the company's current earnings are HK$0.21 Billion. In 2021 the company made an earning of -HK$0.36 Billion, an increase over its 2020 earnings that were of -HK$1.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aerie Pharmaceuticals from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -HK$0.19 Billion-47.71%
2021 -HK$0.36 Billion-70.07%
2020 -HK$1.18 Billion-17.91%
2019 -HK$1.44 Billion-19.83%
2018 -HK$1.8 Billion59.2%
2017 -HK$1.13 Billion50%
2016 -HK$0.75 Billion34.29%
2015 -HK$0.56 Billion51%
2014 -HK$0.37 Billion73.67%
2013 -HK$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$6.08 Billion 3,258.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.58 Billion 769.61%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$128.34 B-71,052.20%๐Ÿ‡บ๐Ÿ‡ธ USA